Paper38017184
An optimization framework to guide the choice of thresholds for risk-based cancer screening.
Brentnall AR and 7 others. NPJ Digit Med, 2023. Cited by 11 papers, by iCite.
Cite this record
ConductScience Library. An optimization framework to guide the choice of thresholds for risk-based cancer screening. Papers, record 38017184. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/38017184
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- An optimization framework to guide the choice of thresholds for risk-based cancer screening.
- PubMed
Topics0
NLM's MeSH indexing of the paper, its major topics first.
None in this release.
Grants3
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by |
|---|---|---|---|---|
| 28396 | Cancer Research UK | United Kingdom | PubMed | |
| 28689 | Cancer Research UK | United Kingdom | PubMed | |
| 2019DecPR1395 | Breast Cancer Now | United Kingdom | PubMed |
Source PubMed
References25
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 35110696 | The projected impact of the COVID-19 lockdown on breast cancer deaths in England due to the cessation of population screening: a national estimation. | Br J Cancer | 2022 | https://conductscience.org/library/papers/35110696 | PubMed |
| 2 | 31848103 | Risk-based breast cancer screening strategies in women. | Best Pract Res Clin Obstet Gynaecol | 2020 | https://conductscience.org/library/papers/31848103 | PubMed |
| 3 | 9864771 | [Detection of cancer, sensitivity of the test and sensitivity of the screening program]. | Rev Epidemiol Sante Publique | 1998 | https://conductscience.org/library/papers/9864771 | PubMed |
| 4 | 17377838 | An overview of prognostic factors for long-term survivors of breast cancer. | Breast Cancer Res Treat | 2008 | https://conductscience.org/library/papers/17377838 | PubMed |
| 5 | 32226220 | Risk Models for Breast Cancer and Their Validation. | Stat Sci | 2020 | https://conductscience.org/library/papers/32226220 | PubMed |
| 6 | 34051753 | Extending screening intervals for women at low risk of breast cancer: do they find it acceptable? | BMC Cancer | 2021 | https://conductscience.org/library/papers/34051753 | PubMed |
| 7 | 29736008 | Psychological impact of providing women with personalised 10-year breast cancer risk estimates. | Br J Cancer | 2018 | https://conductscience.org/library/papers/29736008 | PubMed |
| 8 | 19884547 | Advanced breast cancer and breast cancer mortality in randomized controlled trials on mammography screening. | J Clin Oncol | 2009 | https://conductscience.org/library/papers/19884547 | PubMed |
| 9 | 33844853 | Cost-effectiveness of risk-based breast cancer screening: A systematic review. | Int J Cancer | 2021 | https://conductscience.org/library/papers/33844853 | PubMed |
| 10 | 33504648 | Toward robust mammography-based models for breast cancer risk. | Sci Transl Med | 2021 | https://conductscience.org/library/papers/33504648 | PubMed |
| 11 | 37278627 | Comparison of Mammography AI Algorithms with a Clinical Risk Model for 5-year Breast Cancer Risk Prediction: An Observational Study. | Radiology | 2023 | https://conductscience.org/library/papers/37278627 | PubMed |
| 12 | 17717337 | NICE's cost effectiveness threshold. | BMJ | 2007 | https://conductscience.org/library/papers/17717337 | PubMed |
| 13 | 34767469 | Multi-Institutional Validation of a Mammography-Based Breast Cancer Risk Model. | J Clin Oncol | 2022 | https://conductscience.org/library/papers/34767469 | PubMed |
| 14 | 34575693 | Should Age-Dependent Absolute Risk Thresholds Be Used for Risk Stratification in Risk-Stratified Breast Cancer Screening? | J Pers Med | 2021 | https://conductscience.org/library/papers/34575693 | PubMed |
| 15 | 33937853 | OPTIMAM Mammography Image Database: A Large-Scale Resource of Mammography Images and Clinical Data. | Radiol Artif Intell | 2021 | https://conductscience.org/library/papers/33937853 | PubMed |
| 16 | 37310244 | Evaluation of an AI Model to Assess Future Breast Cancer Risk. | Radiology | 2023 | https://conductscience.org/library/papers/37310244 | PubMed |
| 17 | 10943268 | The Swedish Two-County Trial twenty years later. Updated mortality results and new insights from long-term follow-up. | Radiol Clin North Am | 2000 | https://conductscience.org/library/papers/10943268 | PubMed |
| 18 | 29978189 | Cost-effectiveness and Benefit-to-Harm Ratio of Risk-Stratified Screening for Breast Cancer: A Life-Table Model. | JAMA Oncol | 2018 | https://conductscience.org/library/papers/29978189 | PubMed |
| 19 | 37104728 | Impact of Artificial Intelligence System and Volumetric Density on Risk Prediction of Interval, Screen-Detected, and Advanced Breast Cancer. | J Clin Oncol | 2023 | https://conductscience.org/library/papers/37104728 | PubMed |
| 20 | 35027757 | Optimizing risk-based breast cancer screening policies with reinforcement learning. | Nat Med | 2022 | https://conductscience.org/library/papers/35027757 | PubMed |
Cited by7
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 11 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42149286 | Artificial intelligence for risk-stratified breast cancer screening: a systematic review of evidence, clinical integration, and ethical implications in risk assessment tools. | Radiol Med | 2026 | https://conductscience.org/library/papers/42149286 | PubMed |
| 42069897 | Economic evaluation of artificial intelligence for cancer detection in the UK breast screening programme. | Br J Cancer | 2026 | https://conductscience.org/library/papers/42069897 | PubMed |
| 41881847 | Machine Learning Predicts Hepatocellular Carcinoma Risk from Routine Clinical Data: A Large Population-Based Multicentric Study. | Cancer Discov | 2026 | https://conductscience.org/library/papers/41881847 | PubMed |
| 41623885 | Federated multimodal AI for precision-equitable diabetes care. | Front Digit Health | 2025 | https://conductscience.org/library/papers/41623885 | PubMed |
| 40940998 | Artificial Intelligence-Driven Personalization in Breast Cancer Screening: From Population Models to Individualized Protocols. | Cancers (Basel) | 2025 | https://conductscience.org/library/papers/40940998 | PubMed |
| 39235813 | Cost-Effectiveness of AI for Risk-Stratified Breast Cancer Screening. | JAMA Netw Open | 2024 | https://conductscience.org/library/papers/39235813 | PubMed |
| 38326868 | Are better AI algorithms for breast cancer detection also better at predicting risk? A paired case-control study. | Breast Cancer Res | 2024 | https://conductscience.org/library/papers/38326868 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/38017184
GET https://conductscience.org/api/papers/v1/38017184/references?page=2